Literature DB >> 7680561

Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells.

Y Nunokawa1, N Ishida, S Tanaka.   

Abstract

We previously showed that interferon(IFN)-gamma inhibited the proliferation of rat vascular smooth muscle cells(VSMC) by generation of nitric oxide(NO) through the induction of an NO synthase(NOS). To identify the NOS in the VSMC at molecular level, we analyzed messenger RNA(mRNA) levels and primary structure of the novel NOS by cDNA cloning with application of polymerase chain reaction(PCR). mRNA of the NOS was induced and the level of induction was significantly increased by IFN-gamma in VSMC within a few hours. The amino acid sequence deduced from the cloned NOS cDNA was distinct from that of the previously reported constitutive types of NOSs, while highly similar to that of macrophage NOS. Cofactor binding regions were highly conserved among these NOSs. These findings show that the NOS is inducible and could regulate the proliferation of VSMC. Besides, this is the first report of cloning of the NOS in VSMC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680561     DOI: 10.1006/bbrc.1993.1188

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

1.  Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro.

Authors:  A Papapetropoulos; K M Desai; R D Rudic; B Mayer; R Zhang; M P Ruiz-Torres; G García-Cardeña; J A Madri; W C Sessa
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity.

Authors:  P Rosenkranz-Weiss; W C Sessa; S Milstien; S Kaufman; C A Watson; J S Pober
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Induction of calcium-dependent nitric oxide synthases by sex hormones.

Authors:  C P Weiner; I Lizasoain; S A Baylis; R G Knowles; I G Charles; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 4.  Nitric oxide synthases in mammals.

Authors:  R G Knowles; S Moncada
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

5.  Experimental study on the correlation of nitric oxide with portal hypertensive enteropathy.

Authors:  Y Yu; C Yin; J Yu; K Liang
Journal:  J Tongji Med Univ       Date:  1998

6.  alpha-lipoic acid prevents the induction of iNOS gene expression through destabilization of its mRNA in proinflammatory cytokine-stimulated hepatocytes.

Authors:  Masanori Yamada; Masaki Kaibori; Hironori Tanaka; Kozo Habara; Takeshi Hijikawa; Yoshito Tanaka; Masaharu Oishi; Tadayoshi Okumura; Mikio Nishizawa; A-Hon Kwon
Journal:  Dig Dis Sci       Date:  2012-01-03       Impact factor: 3.199

7.  Inhibition of nitric oxide synthase expression by PPM-18, a novel anti-inflammatory agent, in vitro and in vivo.

Authors:  S M Yu; J F Wu; T L Lin; S C Kuo
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

8.  Tyrosine kinase-dependent and -independent events induced by interleukin-2 stimulation: interleukin-2-mediated NO production required for the induction of lymphokine-activated killer cell activity in rat splenocytes is tyrosine kinase independent.

Authors:  A Juretic; G C Spagnoli; H Hörig; R Shipman; T Kocher; M Samija; M Turic; D Eljuga; F Harder; M Heberer
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

9.  Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.

Authors:  F H Guo; H R De Raeve; T W Rice; D J Stuehr; F B Thunnissen; S C Erzurum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells.

Authors:  N Marczin; T Jilling; A Papapetropoulos; C Go; J D Catravas
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.